The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Ligand and Target Discovery by Fragment-Based Screening in Human Cells
Open accessAbstract
Advances in the synthesis and screening of small-molecule libraries have accelerated the discovery of chemical probes for studying biological processes. Still, only a small fraction of the human proteome has chemical ligands. Here, we describe a platform that marries fragment-based ligand discovery with quantitative chemical proteomics to map thousands of reversible small molecule-protein interactions directly in human cells, many of which can be site-specifically determined. We show that fragment hits can be advanced to furnish selective ligands that affect the activity of proteins heretofore lacking chemical probes. We further combine fragment-based chemical proteomics with phenotypic screening to identify small molecules that promote adipocyte differentiation by engaging the poorly characterized membrane protein PGRMC2. Fragment-based screening in human cells thus provides an extensive proteome-wide map of protein ligandability and facilitates the coordinated discovery of bioactive small molecules and their molecular targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Equipping noncovalent fragments with a photoreactive diazirine moiety similarly enables their proteome-wide target identification without the prerequisite of a particular amino acid in or nearby a ligandable site.98−100”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [98]
In the citing paper
“We recently introduced a strategy that integrates FBLD with chemical proteomics to globally assess small molecule-protein interactions in human cells13.”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“As a consequence, we found that individual FFF probes showed substantial differences in their overall proteomic interaction profiles, which made for complicated structure-activity relationships (SARs) requiring careful manual review to identify fragment-protein interactions that reflected authentic recognition events (versus simply correlating with the overall proteomic interaction profiles of the”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“Moreover, while many of the enantioprobe targets were also enriched by members of the original FFF probe set13, these previous profiles often did not provide useful SAR information, either reflecting substantial enrichment by all of the FFF probes or mirroring the respective global protein interaction footprints of these probes (Supplementary Fig. 2).”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“Nonetheless, we also found that individual FFFs showed substantially different overall protein interaction profiles in human cells, which complicated the assignment of small molecule-protein interactions displaying authentic SARs (vs nonspecific binding to the FFFs).”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“The initial set of fully functionalized (clickable, photoreactive) fragments (FFFs) uncovered many new small molecule-protein interactions, some of which were advanced to selective and cell-active chemical probes.”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“We previously described a chemical proteomic strategy to perform fragment-based ligand discovery experiments in human cells13.”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Large-scale analysis of the yeast proteome by multidimensional protein identification technology
Washburn, M. P., Wolters, D. A., & Yates, J. R. (2001) · Nature Biotechnology · doi:10.1038/85686 · Cited by 4,768
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Computational Methods in Drug Discovery
Sliwoski, G. R., Kothiwale, S., Meiler, J., & Lowe, E. W. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,306
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 2,002
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Fpocket: An open source platform for ligand pocket detection
Guilloux, V. L., Schmidtke, P., & Tufféry, P. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-168 · Cited by 1,724
Quantitative reactivity profiling predicts functional cysteines in proteomes
Weerapana, E., Wang, C., Simon, G. M., Richter, F., Khare, S., Dillon, M. B. D., Bachovchin, D. A., Mowen, K., Baker, D., & Cravatt, B. F. (2010) · Nature · doi:10.1038/nature09472 · Cited by 1,684
Self-citationPrivileged scaffolds for library design and drug discovery
Welsch, M. E., Snyder, S. A., & Stockwell, B. R. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.02.018 · Cited by 1,509
Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
Picotti, P., & Aebersold, R. (2012) · Nature Methods · doi:10.1038/nmeth.2015 · Cited by 1,302
Flagged first, then by citations
Research works printed but not linked: 1
- Gerdes, 1998, Cloning and tissue expression of two putative steroid membrane receptors, Biol. Chem., 379, 907
Cited by
Sorted by citations
Items 201–300 of 445
Fragment-Based Approaches to Identify RNA Binders
Suresh, B. M., Taghavi, A., Childs‐Disney, J. L., & Disney, M. D. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00034 · Cited by 23
Mapping the Small Molecule Interactome by Mass Spectrometry
Flaxman, H. A., & Woo, C. M. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b01038 · Cited by 21
Chang, C., Mfuh, A. M., Gao, J., Wu, H., & Woo, C. M. (2018) · Tetrahedron · doi:10.1016/j.tet.2018.03.024 · Cited by 22
McClure, R. A., & Williams, J. D. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00181 · Cited by 21
Lu, K., Hou, W. S., Xu, X., Chen, Q., Li, Z., Lin, J., & Chen, W. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.112026 · Cited by 21
Lanyon‐Hogg, T., Ritzefeld, M., Zhang, L., Andrei, S. A., Pogranyi, B., Mondal, M., Sefer, L., Johnston, C. D., Coupland, C. E., Greenfield, J. L., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202014457 · Cited by 21
Fragment-based screening: A new paradigm for ligand and target discovery
Knight, S., Gianni, D., & Hendricks, A. (2022) · SLAS DISCOVERY · doi:10.1016/j.slasd.2021.10.011 · Cited by 20
Chemically triggered crosslinking with bioorthogonal cyclopropenones
Row, R. D., Nguyen, S. S., Ferreira, A. J., & Prescher, J. A. (2020) · Chemical Communications · doi:10.1039/d0cc04600k · Cited by 20
Modular Approaches to Synthesize Activity- and Affinity-Based Chemical Probes
van der Zouwen, A. J., & Witte, M. D. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.644811 · Cited by 21
Total Synthesis as a Vehicle for Collaboration
Morrill, L. A., Susick, R. B., Chari, J. V., & Garg, N. K. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b05588 · Cited by 19
Choi, H. W., Wang, L., Powell, A. F., Strickler, S. R., Wang, D., Dempsey, D. A., Schroeder, F. C., & Klessig, D. F. (2019) · Scientific Reports · doi:10.1038/s41598-019-49234-6 · Cited by 20
Cleavable linkers and their application in MS-based target identification
Beard, H. A., Korovesis, D., Chen, S., & Verhelst, S. H. L. (2021) · Molecular Omics · doi:10.1039/d0mo00181c · Cited by 20
Transcriptome-Wide, Unbiased Profiling of Ribonuclease Targeting Chimeras
Tong, Y., Su, X., Rouse, W. B., Childs‐Disney, J. L., Taghavi, A., Zanon, P. R. A., Kovachka, S., Wang, T., Moss, W. N., & Disney, M. D. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c04717 · Cited by 20
Fragment-Based Drug Discovery of Phosphodiesterase Inhibitors
Svensson, F., Bender, A., & Bailey, D. S. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00404 · Cited by 19
Stepek, I. A., Cao, T., Koetemann, A., Shimura, S., Wollscheid, B., & Bode, J. W. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00227 · Cited by 18
Racioppo, B., Pechalrieu, D., Abegg, D., Dwyer, B. G., Ramseier, N. T., Hu, Y., & Adibekian, A. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c17827 · Cited by 18
Photoreactive bioorthogonal lipid probes and their applications in mammalian biology
Shanbhag, K., Sharma, K., & Kamat, S. S. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00174h · Cited by 17
Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice
Punetha, A., & Kotiya, D. (2023) · Proteomes · doi:10.3390/proteomes11010002 · Cited by 17
A Photo-clickable ATP-Mimetic Reveals Nucleotide Interactors in the Membrane Proteome
Jelcic, M., Wang, K., Hui, K. L., Cai, X.-C., Enyedi, B., Luo, M., & Niethammer, P. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.05.010 · Cited by 17
Miyajima, R., Sakai, K., Otani, Y., Wadatsu, T., Sakata, Y., Nishikawa, Y., Tanaka, M., Yamashita, Y., Hayashi, M., Kondo, K., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00335 · Cited by 17
Selectivity aspects of activity-based (chemical) probes
Heinzlmeir, S., & Müller, S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.021 · Cited by 17
Hong, X.-Q., Geng, P., Tian, N., Li, X., Gao, M., Nie, L., Sun, Z., & Liu, G. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c04293 · Cited by 16
Chemoproteomic mapping of human milk oligosaccharide (HMO) interactions in cells
Hassan, A. A., Wozniak, J. M., Vilen, Z., Li, W., Jadhav, A. M., Parker, C. G., & Huang, M. L. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00176d · Cited by 17
Self-citationEFMC: Trends in Medicinal Chemistry and Chemical Biology
Auberson, Y. P., Arimondo, P. B., Duca, M., Essig, S., Grether, U., Rufer, A. C., Sbardella, G., Schopfer, U., Torrens, A., van der Stelt, M., et al. (2023) · ChemBioChem · doi:10.1002/cbic.202200690 · Cited by 16
Multigram Synthesis of Functionalized Spirocyclic Diazirines
Martyloga, O. V., Myronenko, A., Tkachenko, A. M., Matvienko, V. O., Kuchkovska, Y. O., & Grygorenko, O. O. (2019) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201900485 · Cited by 16
Ali, R., Guan, Y., Leveille, A. N., Vaughn, E., Parelkar, S. S., Thompson, P. R., & Mattson, A. E. (2019) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201901026 · Cited by 16
Bracken, A. K., Gekko, C. E., Suss, N. O., Lueders, E. E., Cui, Q., Fu, Q., Lui, A. C. W., Anderson, E. T., Zhang, S., & Abbasov, M. E. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c10741 · Cited by 16
Labelled Chemical Probes for Demonstrating Direct Target Engagement in Living Systems
Prevet, H., & Collins, I. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0370 · Cited by 15
Castaldi, M. P., Hendricks, J. A., & Zhang, A. X. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.03.003 · Cited by 15
A chiral trick to map protein ligandability
Amako, Y., & Woo, C. M. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0380-0 · Cited by 15
Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
Konaklieva, M. I., & Plotkin, B. J. (2023) · Antibiotics · doi:10.3390/antibiotics12020315 · Cited by 14
Ye, Y., Li, K., Ma, Y., Zhang, X., Li, Y., Yu, T., Wang, Y., & Ye, M. (2023) · Molecules · doi:10.3390/molecules28124859 · Cited by 15
Self-citationChemical Screening of Nuclear Receptor Modulators
Ishigami‐Yuasa, M., & Kagechika, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155512 · Cited by 15
LEADS-FRAG: A Benchmark Data Set for Assessment of Fragment Docking Performance
Chachulski, L., & Windshügel, B. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00693 · Cited by 16
Zhang, Y., Lan, Y., Fan, R., Feng, L., Wang, G., Wu, X., Wen, L., Duan, Z., Xia, Y., Wang, X., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c14634 · Cited by 13
Zheng, B., Guo, H., Ma, N., Ni, Y., Xu, J., Li, L., Hao, P., Ding, K., & Li, Z. (2018) · Chemistry - An Asian Journal · doi:10.1002/asia.201800605 · Cited by 13
Long, M. J. C., Zhao, Y., & Aye, Y. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00041h · Cited by 13
Schmerling, C., Sewald, L., Heilmann, G., Witfeld, F., Begerow, D., Jensen, K., Bräsen, C., Kaschani, F., Overkleeft, H. S., Siebers, B., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04141-x · Cited by 13
Fragment‐Based Phenotypic Lead Discovery: Cell‐Based Assay to Target Leishmaniasis
Ayotte, Y., Bilodeau, F., Descoteaux, A., & LaPlante, S. R. (2018) · ChemMedChem · doi:10.1002/cmdc.201800161 · Cited by 13
An in situ combinatorial methodology to synthesize and screen chemical probes
van der Zouwen, A. J., Lohse, J., Wieske, L. H. E., Hohmann, K. F., van der Vlag, R., & Witte, M. D. (2019) · Chemical Communications · doi:10.1039/c8cc06991c · Cited by 14
Identifying and validating small molecules interacting with RNA (SMIRNAs)
Disney, M. D., Velagapudi, S. P., Li, Y., Costales, M. G., & Childs‐Disney, J. L. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.04.027 · Cited by 13
Targeting extrachromosomal DNA in human cancers
Wong, I. T.-L., Yi, H., Melillo, B. N., Cravatt, B. F., Chang, H. Y., & Mischel, P. S. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01369-0 · Cited by 12
Self-citationLiao, Y., Chan, S. C., Welsh, E. A., Fang, B., Sun, L., Schönbrunn, E., Koomen, J. M., Duckett, D. R., Haura, E. B., Monastyrskyi, A., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00587 · Cited by 12
Wei, H., Zhang, T., Li, Y., Zhang, G., & Li, Y. (2023) · Chemistry - An Asian Journal · doi:10.1002/asia.202300652 · Cited by 12
A chemoproteomic platform for selective deubiquitinase inhibitor discovery
Cookson, R., Vuorinen, A., Pettinger, J., Kennedy, C. R., Kirkpatrick, J. M., Heap, R. E., Powell, A., Snijders, A. P., Skehel, M. J., House, D., et al. (2023) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2023.101636 · Cited by 12
Oxadiazolines as Photoreleasable Labels for Drug Target Identification
Bon, C., Goretzki, B., Flamme, M., Shelton, C., Davis, H. J., Lima, F., García, F., Brittain, S. M., & Brocklehurst, C. E. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c06936 · Cited by 12
Chemical proteomic mapping of reversible small molecule binding sites in native systems
Wozniak, J. M., Li, W., & Parker, C. G. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.09.001 · Cited by 15
Self-citationPatil, C., Priyanka, R., Harshitha, B., Oshik, S., Yashwanth, S., Darshan, B., Patil, S., Prajwal, K. A., Naik, P., Prakash Goudanavar, S. O. P., et al. (2025) · Medical Oncology · doi:10.1007/s12032-025-02944-6 · Cited by 12
Proteome-Wide Discovery of Degradable Proteins Using Bifunctional Molecules
Forrest, I., Conway, L. P., Gathmann, C., Jadhav, A. M., Chiu, T.-Y., Chaheine, C. M., Estrada, M. A., Shrestha, A., Sarris, K., Reitsma, J. M., et al. (2025) · ACS Central Science · doi:10.1021/acscentsci.5c01594 · Cited by 12
Self-citationDiscovery of Modulators of Adipocyte Physiology Using Fully Functionalized Fragments
Galmozzi, A., Parker, C. G., Kok, B. P., Cravatt, B. F., & Sáez, E. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7847-2_9 · Cited by 12
Self-citationCanning, P., Birchall, K., Kettleborough, C. A., Merritt, A. T., & Coombs, P. J. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.003 · Cited by 12
Chan, H., Lin, X., Fan, S., Hwu, J. R., & Tan, K. (2020) · Chemistry - An Asian Journal · doi:10.1002/asia.202001049 · Cited by 12
Lin, K., Lam, C. H., Lin, X., Hsu, J., Fan, S., Gupta, N. K., Lin, Y., Tee, B. K., Li, J. M., Chen, J., et al. (2021) · Chemistry - An Asian Journal · doi:10.1002/asia.202100060 · Cited by 12
Dong, J., Du, X., Zhang, Y., Zhuang, T., Cui, X., & Li, Z. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.112109 · Cited by 12
Fragment-Based Phenotypic Lead Discovery To Identify New Drug Seeds That Target Infectious Diseases
Ayotte, Y., Bernet, È., Bilodeau, F., Cimino, M., Gagnon, D., Lebughe, M., Mistretta, M., Ogadinma, P., Ouali, S.-L., Sow, A. A., et al. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00657 · Cited by 12
Oxidant-Induced Bioconjugation for Protein Labeling in Live Cells
Liu, Y., Liu, J.-C., Zhang, X., Guo, C., Xing, X., Zhang, Z., Ding, K., & Li, Z. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00740 · Cited by 12
Quantitative Chemoproteomic Methods for Reactive Cysteinome Profiling
Xiao, W., Chen, Y., & Wang, C. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202200100 · Cited by 12
Jackson, P., & Lapinsky, D. J. (2018) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b01831 · Cited by 12
Kovachka, S., Wang, J., Taghavi, A., Jia, Y., Asaba, T., Wolff, K. C., Martin, M., Yang, X., Meyer, S. M., Ottilie, S., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c11898 · Cited by 11
Fast and Site-Specific Covalent Targeting of Proteins by Arylfluorosulfate-Modified Aptamers
Zhang, K., Li, J., Shi, Y., Hou, S., Qin, Z., Shi, W., Zhu, Y., Zhang, J., Tong, A., & Xiang, Y. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c14374 · Cited by 11
Emerging opportunities for intact and native protein analysis using chemical proteomics
Edwards, A. N., & Hsu, K. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.343551 · Cited by 11
Affecting RNA biology genome-wide by binding small molecules and chemically induced proximity
Baisden, J. T., Childs‐Disney, J. L., Ryan, L. S., & Disney, M. D. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.03.006 · Cited by 12
Kundu, S., Lin, C., Jaiswal, M., Mullapudi, V., Craig, K. C., Chen, S., & Guo, Z. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00728 · Cited by 11
Pharmacological Modulation of Transcriptional Coregulators in Cancer
Bishop, T. R., Zhang, Y., & Erb, M. A. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.04.004 · Cited by 11
Yang, X., Wang, J., Springer, N. A., Zanon, P. R. A., Jia, Y., Su, X., & Disney, M. D. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf231 · Cited by 10
Covalent fragment mapping of KRasG12C revealed novel chemotypes with in vivo potency
Orgován, Z., Péczka, N., Petri, L., Ábrányi‐Balogh, P., Ranđelović, I., Tóth, S., Szakács, G., Nyíri, K., Vértessy, B. G., Pálfy, G., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115212 · Cited by 10
Quantification of Binding of Small Molecules to Native Proteins Overexpressed in Living Cells
Yin, Y., Zhao, L., Rane, D., Lin, Z., Wu, M., & Peterson, B. R. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c07488 · Cited by 10
Perturbation-Based Proteomic Correlation Profiling as a Target Deconvolution Methodology
Ohki, Y., Sakurai, H., Hoshino, M., Terashima, H., Shimizu, H., ISHIKAWA, T., Ogiyama, T., Muramatsu, Y., Nakanishi, T., Miyazaki, S., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.10.012 · Cited by 10
Interaction profiling methods to map protein and pathway targets of bioactive ligands
Huang, J., Coukos, J. S., & Moellering, R. E. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.02.001 · Cited by 10
What is the Future for Fragment-Based Drug Discovery?
Keserű, G. M., & Hann, M. M. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0106 · Cited by 10
Mapping protein binding sites by photoreactive fragment pharmacophores
Ábrányi‐Balogh, P., Bajusz, D., Orgován, Z., Keeley, A. B., Petri, L., Péczka, N., Szalai, T. V., Pálfy, G., Gadanecz, M., Grant, E. K., et al. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01252-w · Cited by 9
Target‐Templated Construction of Functional Proteomimetics Using Photo‐Foldamer Libraries
Wéber, E., Ábrányi‐Balogh, P., Nagymihály, B., Menyhárd, D. K., Péczka, N., Gadanecz, M., Schlosser, G., Orgován, Z., Bogár, F., Bajusz, D., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202410435 · Cited by 9
The contribution of cyclic imide stereoisomers on cereblon-dependent activity
Amako, Y., Ichikawa, S., Lloyd, H. C., Payne, N. C., Lin, Z., Boghossian, A. S., Rees, M. G., Ronan, M. M., Roth, J. A., Zhu, Q., et al. (2025) · Chemical Science · doi:10.1039/d5sc01371b · Cited by 9
Tan, X., Wang, D., Yao, Y., Liu, K., Chen, Y., Fu, S., & Ni, F. (2025) · PROTEOMICS · doi:10.1002/pmic.70019 · Cited by 9
One‐Step Synthesis of Photoaffinity Probes for Live‐Cell MS‐Based Proteomics
Fallon, D. J., Lehmann, S., Chung, C., Phillipou, A., Eberl, C., Fantom, K. G. M., Zappacosta, F., Patel, V. K., Bantscheff, M., Schofield, C. J., et al. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202102036 · Cited by 9
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–7
Gütschow, M., Eynde, J. J. V., Jampílek, J., Kang, C., Mangoni, A. A., Fossa, P., Karaman, R., Trabocchi, A., Scott, P. J. H., Reynisson, J., et al. (2020) · Molecules · doi:10.3390/molecules25132968 · Cited by 9
Gain‐of‐function of progesterone receptor membrane component 2 ameliorates ischemic brain injury
Zhou, C., Zhu, T., Ni, W., Zhou, H., Song, J., Wang, M., Jin, G., Zhou, Y., Han, J., & Hua, F. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14122 · Cited by 9
Enantioselective protein affinity selection mass spectrometry (E-ASMS)
Wang, X., Sun, J., Ahmad, S., Yang, D., Li, F., Chan, U. H., Zeng, H., Simoben, C. V., Green, S. R., Silva, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67403-2 · Cited by 11
Chemoproteomic Profiling of a Pharmacophore-Focused Chemical Library
Punzalan, L. L., Jiang, L., Mao, D., Mahapatra, A. D., Sato, S., Takemoto, Y., Tsujimura, M., Kusamori, K., Nishikawa, M., Zhou, L., et al. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.04.007 · Cited by 9
A tubulin binding molecule drives differentiation of acute myeloid leukemia cells
Jackson, T., Vuorinen, A., Josa‐Culleré, L., Madden, K. S., Conole, D., Cogswell, T. J., Wilkinson, I. V. L., Kettyle, L. M., Zhang, D., O’Mahony, A., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104787 · Cited by 10
Chemical probes for the identification of the molecular targets of honokiol
Vázquez‐Villa, H., Rueda‐Zubiaurre, A., Fernández, D., Foronda-Sainz, R., Parker, C. G., Cravatt, B. F., Martín‐Fontecha, M., & Ortega‐Gutiérrez, S. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117102 · Cited by 8
Self-citationPosttranslational modifications remodel proteome-wide ligandability
Li, W., Wei, Q., Llanos, M. A., Gathmann, C., Governa, P., Chiu, T.-Y., Wozniak, J. M., Jadhav, A. M., Holcomb, M., Cravatt, J. B., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02216-y · Cited by 9
Self-citationZhu, D., Guo, H., Chang, Y., Ni, Y., Li, L., Zhang, Z., Hao, P., Xu, Y., Ding, K., & Li, Z. (2018) · Angewandte Chemie · doi:10.1002/ange.201802003 · Cited by 8
Role of structural biology methods in drug discovery
Nasim, F., & Qureshi, I. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90264-9.00022-2 · Cited by 8
A Photoaffinity‐Based Fragment‐Screening Platform for Efficient Identification of Protein Ligands
Grant, E. K., Fallon, D. J., Hann, M. M., Fantom, K. G. M., Quinn, C. J., Zappacosta, F., Annan, R. S., Chung, C., Bamborough, P., Dixon, D. P., et al. (2020) · Angewandte Chemie · doi:10.1002/ange.202008361 · Cited by 8
Exiting the tunnel of uncertainty: crystal soak to validated hit
Martin, M. P., & Noble, M. E. M. (2022) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798322009986 · Cited by 9
MS methods to study macromolecule-ligand interaction: Applications in drug discovery
Sirtori, F. R., Altomare, A., Carini, M., Aldini, G., & Regazzoni, L. (2018) · Methods · doi:10.1016/j.ymeth.2018.06.005 · Cited by 8
Kellie, J. F., Sikorski, T. W., An, B., Chen, Z., Moghieb, A. H., Busz, M., Szapacs, M. E., & Angel, T. E. (2019) · Bioanalysis · doi:10.4155/bio-2019-0191 · Cited by 8
Mitochondrial Function and Dysfunction in White Adipocytes and Therapeutic Implications
Wang, F., Huynh, P. M., & An, Y. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230009 · Cited by 10
O’Brien, J. G. K., Conway, L. P., Ramaraj, P. K., Jadhav, A. M., Jin, J., Dutra, J. K., Evers, P., Masoud, S. S., Schupp, M., Saridakis, I., et al. (2024) · Chemical Science · doi:10.1039/d4sc04238g · Cited by 7
Self-citationRegulation of RNA-binding proteins by small biomolecules
Miao, W., Porter, D. F., Lopez-Pajares, V., & Khavari, P. A. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00914-4 · Cited by 7
Miyajima, R., Tanegashima, K., Naruse, N., Denda, M., Hara, T., & Otaka, A. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.3c00717 · Cited by 7
Sabbir, M. G., Inoue, A., Taylor, C. G., & Zahradka, P. C. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105995 · Cited by 7
Expanding chemogenomic space using chemoproteomics
Jones, L. H. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.06.022 · Cited by 7
Plowright, A. T., & Drowley, L. (2017) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2017.07.001 · Cited by 7
Receptor Binding Assays and Drug Discovery
Bylund, D. B., & Enna, S. J. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.08.007 · Cited by 7
Terai, T., Koike, T., & Nemoto, N. (2020) · Molecules · doi:10.3390/molecules25061472 · Cited by 7
Chemically Programmable and Switchable CAR‐T Therapy
Qi, J., Tsuji, K., Hymel, D., Burke, T. R., Hudecek, M., Rader, C. M., & Peng, H. (2020) · Angewandte Chemie · doi:10.1002/ange.202005432 · Cited by 7
Affinity‐Based Chemoproteomics for Target Identification
Jensen, A. J., & Cornella‐Taracido, I. (2019) · Methods and principles in medicinal chemistry · doi:10.1002/9783527818242.ch2 · Cited by 7
The limitations of small molecule and genetic screening in phenotypic drug discovery
Vincent, F., & Gianni, D. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.10.008 · Cited by 6
Metadata
- Authors
- Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., & Cravatt, B. F.
- Affiliations
- Scripps Research Institute (US)
- École Polytechnique Fédérale de Lausanne (CH)
- Bristol-Myers Squibb (United States) (US)
- Salk Institute for Biological Studies (US)
- Corresponding author
- Parker, Christopher G.
- Cravatt, Benjamin F.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 168
- Issue
- 3
- Pages
- 527-541.e29
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC5632530
- OpenAlex
- W2575838842
- Cited by
- 439
- References
- 59
- Citations by year
- 2026: 29 · 2025: 44 · 2024: 42 · 2023: 49 · 2022: 55 · 2021: 50 · 2020: 49 · 2019: 52 · 2018: 39 · 2017: 29
- FWCI
- 19.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- American Cancer Society (PF-14-100-01-CDD)
- American Heart Association (14POST18200019)
- NIH (DK099810, CA132630, 1S10OD16357)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- fragment screening, chemical probes, protein-ligand interactions, human proteome, target identification, PGRMC2, adipogenesis, membrane proteins, site-specific binding, phenotypic screening, ligand discovery
- MeSH terms
- Cell Differentiation, Humans, Hydrolases, Ligands, Membrane Proteins, Oxidoreductases, Protein Binding, Receptors, Progesterone, Adipocytes, Crystallography, X-Ray, Proteomics, Small Molecule Libraries, Drug Discovery, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
